About Us
Progenetics is a pioneering company in the field of personalized cancer medicine in Israel.
The company was founded in 2015 by Dr. Yoav Menaster and Dror Kartesh, and today represents approximately 15 of the world’s leading laboratories in the field. Progenetics offers the broadest range of tests in Israel, works with all hospitals across the country, and collaborates closely with the oncology community.
Progenetics performs thousands of tests each year, while adhering to international standards of shipping and customer service.
In addition, the company is active in academic research, in collaboration with institutions such as the Weizmann Institute of Science, Tel Aviv University, the Hebrew University, and others.
Progenetics offers genetic tests in the following areas:
- Treatment-matching tests based on solid tumor biopsy
- Treatment-matching tests based on blood samples — liquid biopsy
- Second opinion for pathological diagnosis
- Tests for identifying hereditary cancer risk
- Assessment of the benefit of hormonal therapy for breast cancer
- Advanced immune profiling, and more…
We will be happy to assist you in finding the most advanced treatment personally tailored for you.
You are welcome to contact us with any question — we will be happy to advise and assist.
Our Team
Dr. Yoav Menaster
CEO and Founder
Dr. Tamar Zehavi
Scientific Director
Meital Laskar
Marketing Manager
Avishag Zimberg Bossira
VP Operations
Sivan Zomerstein
Operations and Administration
Daniel Nissim
Operations and Administration Manager
Adeli Meitin
Operations and Administration
Sigal Tzadok
Operations and Administration
Miri Chen
Product Specialist and Business Development
Dorit Moses
VP Headquarters
Yulia Davidovsky
Registered Nurse
Dr. Omer Almog
Scientific Advisor
“`
